Skip to main content

Table 3 International Prostate Symptom Score (IPSS)

From: 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment

 

Baseline (Mean ± SD)

Post-RT (Mean ± SD)

p

IPSS score

5.4 ± 3.7

7 ± 4.5

0,07